GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Animalcare Group PLC (LSE:ANCR) » Definitions » Cash And Cash Equivalents

Animalcare Group (LSE:ANCR) Cash And Cash Equivalents : £4.64 Mil (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Animalcare Group Cash And Cash Equivalents?

Animalcare Group's quarterly cash and cash equivalents increased from Dec. 2022 (£6.04 Mil) to Jun. 2023 (£6.61 Mil) but then stayed the same from Jun. 2023 (£6.61 Mil) to Dec. 2023 (£4.64 Mil).

Animalcare Group's annual cash and cash equivalents increased from Dec. 2021 (£5.63 Mil) to Dec. 2022 (£6.04 Mil) but then declined from Dec. 2022 (£6.04 Mil) to Dec. 2023 (£4.64 Mil).


Animalcare Group Cash And Cash Equivalents Historical Data

The historical data trend for Animalcare Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Animalcare Group Cash And Cash Equivalents Chart

Animalcare Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.17 5.27 5.63 6.04 4.64

Animalcare Group Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.63 5.14 6.04 6.61 4.64

Animalcare Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Animalcare Group  (LSE:ANCR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Animalcare Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Animalcare Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Animalcare Group (LSE:ANCR) Business Description

Traded in Other Exchanges
Address
Monks Cross Drive, Moorside, York, GBR, YO32 9LB
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

Animalcare Group (LSE:ANCR) Headlines

No Headlines